TEN4CARE at TERMIS-EU 2026: Advancing the Conversation on Smart Biomaterials and Regulatory Innovation
Biokeralty Research Institute, as a partner of the TEN4CARE consortium, is pleased to highlight the significant presence of the project at the TERMIS-EU 2026 Annual Conference, held at the Palau de Congressos de Palma in Palma de Mallorca (Spain) from 21 to 24 April 2026.
Organised under the theme “Accelerating multidisciplinary innovation to close the gap in clinical translation", the conference brought together leading researchers, clinicians and industry experts in tissue engineering and regenerative medicine from across Europe and beyond — a gathering fully aligned with Biokeralty’s commitment to advancing regenerative medicine and its translation into clinical practice.
TEN4CARE’s Contributions to the Conference
The TEN4CARE team played an active and multifaceted role at the event, spanning session chairing, invited talks and scientific presentations — reflecting both the breadth of the project and the strength of its consortium.
The project’s principal investigator, Giuseppina Sandri (University of Pavia), chaired the parallel symposium “Biomaterials: Design, Development and Regulatory Issues" — a session of particular strategic relevance to TEN4CARE, whose work centres on the development of innovative biomaterials for clinical application.
Within this symposium, Sandra Ferretti delivered an invited presentation titled “Regulatory Framework for Innovative Smart Biomaterials", addressing the evolving regulatory landscape for smart biomaterials — one of the key dimensions guiding the project’s translational strategy.
The team also presented a paper entitled “Thermosensitive smart composite scaffolds for cartilage repair", showcasing the project’s latest technical advances in the development of next-generation scaffolding solutions.
Bridging Science and Clinical Translation
TEN4CARE’s participation at TERMIS-EU 2026 reflects a clear commitment to connecting cutting-edge biomaterial science with the regulatory and clinical translation challenges that define the path to real-world impact. From injectable hydrogels and smart scaffolds to regulatory frameworks, the work presented in Palma demonstrates the depth and breadth of the research being carried out across the consortium.
As a TEN4CARE partner, Biokeralty contributes to this mission by bringing its and its role as a bridge between European research and clinical practice. We look forward to continuing to share progress with the tissue engineering and regenerative medicine community at upcoming scientific events.
Stay tuned for more updates on TEN4CARE on https://ten4care-project.eu/news/
